Next Article in Journal
Fabrication of Chitosan/Silk Fibroin Composite Nanofibers for Wound-dressing Applications
Next Article in Special Issue
Modulation of Huntingtin Toxicity by BAG1 is Dependent on an Intact BAG Domain
Previous Article in Journal
Interferon-alpha Induces High Expression of APOBEC3G and STAT-1 in Vitro and in Vivo
Previous Article in Special Issue
Kinin Receptor Antagonists as Potential Neuroprotective Agents in Central Nervous System Injury
Int. J. Mol. Sci. 2010, 11(9), 3513-3528; doi:10.3390/ijms11093513
Review

Human Umbilical Cord Blood Stem Cells: Rational for Use as a Neuroprotectant in Ischemic Brain Disease

1,2
,
1
,
2
 and
1,*
Received: 18 August 2010 / Revised: 15 September 2010 / Accepted: 15 September 2010 / Published: 21 September 2010
(This article belongs to the Special Issue Neuroprotective Strategies (special issue))
View Full-Text   |   Download PDF [283 KB, uploaded 19 June 2014]

Abstract

The use of stem cells for reparative medicine was first proposed more than three decades ago. Hematopoietic stem cells from bone marrow, peripheral blood and human umbilical cord blood (CB) have gained major use for treatment of hematological indications. CB, however, is also a source of cells capable of differentiating into various non-hematopoietic cell types, including neural cells. Several animal model reports have shown that CB cells may be used for treatment of neurological injuries. This review summarizes the information available on the origin of CB-derived neuronal cells and the mechanisms proposed to explain their action. The potential use of stem/progenitor cells for treatment of ischemic brain injuries is discussed. Issues that remain to be resolved at the present stage of preclinical trials are addressed.
Keywords: human umbilical cord blood stem cells; brain ischemia; neuroprotection human umbilical cord blood stem cells; brain ischemia; neuroprotection
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Arien-Zakay, H.; Lecht, S.; Nagler, A.; Lazarovici, P. Human Umbilical Cord Blood Stem Cells: Rational for Use as a Neuroprotectant in Ischemic Brain Disease. Int. J. Mol. Sci. 2010, 11, 3513-3528.

View more citation formats

Related Articles

Article Metrics

Comments

Citing Articles

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert